ArticleThe Journal of pharmacology and experimental therapeutics2019

Inhibition of CD38 with the Thiazoloquin(az)olin(on)e 78c Protects the Heart against Postischemic Injury.

James Boslett et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.